Matthew is a co-founder of Isomerase and was CEO from its formation for just over 10 years until July 2023. He has over 20 years of experience in microbial bioengineering and bioinformatics, is an author or inventor on over 40 patents, patent applications or publications and holds a BSc in Biochemistry and Genetics and a PhD in Molecular Genetics from the University of Nottingham. He is skilled in programme management and intellectual property rights protection, with experience generating and managing broad IP portfolios for technology and drug discovery biotech companies and was previously Director of Intellectual Property and Project Management at Biotica Technology Ltd. He joined Biotica in 2003, having been involved with the company since 1999 when he was at the University of Cambridge working on genetic manipulation of biosynthetic pathways in Professor Peter Leadlay’s group.

ico linkedin

Cookies user preferences
All essential cookies are mandatory in order to allow logging in and submitting forms etc. You can choose to decline some non-essential ones.
Accept all
Decline all
Read more
Tools used to analyze the data to measure the effectiveness of a website and to understand how it works.